Transforming the lives of rheumatic patients

So far this year, we have achieved remarkable health outcomes among our patients living with the two most common rheumatic diseases we treat: Lupus and Rheumatoid Arthritis (RA). Currently, 44% of our patients live with RA and 17% with Lupus. Thanks to continuous access to specialized medical care, treatment, and emotional support, 77.4% of our Lupus patients and 43.9% of our RA patients have reached remission — meaning they are experiencing no active symptoms of the disease. For people living with chronic autoimmune conditions, achieving remission can be life-changing: it reduces pain and inflammation, prevents irreversible organ and joint damage, improves emotional wellbeing, and allows patients to regain independence, return to work, care for their families, and rebuild their quality of life. These results reflect the profound impact that timely and sustained treatment can have, especially for patients who otherwise face significant barriers to accessing specialized care and medication.